Form 4 for OKYO OKYO Pharma Ltd
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-17 · accession 0001493152-22-014284 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-05-18 | 2022-05-17 | OKYO | CERRONE GABRIELE M | Non-Executive COB, Dir, 10% | P - Purchase | $0.06 | +1.62M | 544.81M | +0.3% | +$97.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-05-17 | P | A | 1,625,000 | $0.06 | 544,806,215 | I Via Panetta Partners Limited | — | — |